Related Experiment Video
Updated: Aug 9, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Second primary malignancies in the head and neck cancer patient
1Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Abstract:
With improvements in locoregional control, the problem of second primary malignancies is rapidly being pushed to the forefront of head and neck oncology. While the constant long-term risk for the head and neck cancer patient has been well established, efforts at prevention, early detection, and treatment have been somewhat futile. Recent advances in genetic predisposition, biomarkers, photodiagnostic imaging, and differentiation therapy may soon offer improved outcomes. The literature is reviewed and current research is presented regarding the history, epidemiology, etiology, diagnosis, and treatment of second primary malignancies.
Insights
Second primary malignancies are an increasing concern in head and neck cancer care. Advances in genetics, biomarkers, and imaging offer hope for better prevention, detection, and treatment of these secondary cancers.
Area of Science:
- Oncology
- Cancer Research
Background:
- Improving locoregional control in head and neck cancer highlights the growing challenge of second primary malignancies.
- The long-term risk of developing secondary cancers in head and neck cancer patients is significant, yet current prevention and treatment strategies remain limited.
Purpose of the Study:
- To review the current literature and present research on the history, epidemiology, etiology, diagnosis, and treatment of second primary malignancies in head and neck cancer patients.
Main Methods:
- Literature review
- Presentation of current research findings.
Main Results:
- The study reviews the historical context, epidemiological data, etiological factors, diagnostic approaches, and therapeutic options for second primary malignancies.
- Recent scientific advancements in genetic predisposition, biomarkers, photodiagnostic imaging, and differentiation therapy show potential for improving patient outcomes.
Conclusions:
- Second primary malignancies represent a critical and evolving issue in head and neck oncology.
- Emerging technologies and therapies hold promise for enhancing the management of these secondary cancers, necessitating continued research and clinical focus.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

